Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,450 | -1,610 | -760 | -3,010 | -2,360 |
| Depreciation Amortization | 30 | 20 | 10 | 100 | 70 |
| Other Working Capital | 9 | -40 | -100 | 140 | 40 |
| Other Operating Activity | 201 | 120 | 70 | 410 | 310 |
| Operating Cash Flow | $-2,210 | $-1,510 | $-780 | $-2,360 | $-1,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -7 | -6 | 0 | 0 |
| Other Investing Activity | 187 | 187 | 196 | -220 | -10 |
| Investing Cash Flow | $180 | $180 | $190 | $-220 | $-10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 210 | 0 | 0 | 5,120 | 5,120 |
| Financing Cash Flow | $210 | $0 | $0 | $5,120 | $5,120 |
| Beginning Cash Position | 2,740 | 2,740 | 2,740 | 210 | 210 |
| End Cash Position | 930 | 1,420 | 2,150 | 2,740 | 3,370 |
| Net Cash Flow | $-1,810 | $-1,320 | $-590 | $2,530 | $3,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,210 | -1,510 | -780 | -2,360 | -1,940 |
| Free Cash Flow | -2,210 | -1,510 | -780 | -2,360 | -1,940 |